Back to mobile site

'Caris Life Sciences Inc (CAI) is out best value story'; PT Lowered to $31 at TD Cowen

April 13, 2026 8:49 AM EDT Send to a Friend
TD Cowen analyst Dan Brennan lowered the price target on Caris Life Sciences Inc (NASDAQ: CAI) to $31.00 (from $35.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login